Dynamic Atlas-Based Segmentation and Quantification of Neuromelanin-Rich Brainstem Structures in Parkinson Disease

We present a dynamic atlas composed of neuromelanin-enhanced magnetic resonance brain images of 40 healthy subjects. The performance of this atlas is evaluated on the fully automated segmentation of two paired neuromelanin-rich brainstem healthy structures: the substantia nigra pars compacta and the locus coeruleus. We show that our dynamic atlas requires in average 60% less images and, therefore, 60% less computation time than a static multi-image atlas while achieving a similar segmentation performance. Then, we show that by applying our dynamic atlas, composed of healthy subjects, to the segmentation and neuromelanin quantification of a set of brain images of 39 Parkinson disease patients, we are able to find significant quantitative differences in the level of neuromelanin between healthy subjects and Parkinson disease patients, thus opening the door to the use of these structures as image biomarkers in future computer aided diagnosis systems for the diagnosis of Parkinson disease.

[1]  Daniel Rueckert,et al.  Nonrigid registration using free-form deformations: application to breast MR images , 1999, IEEE Transactions on Medical Imaging.

[2]  Takashi Nihashi,et al.  Visualization of neuromelanin in the Substantia nigra and locus ceruleus at 1.5T using a 3D-gradient echo sequence with magnetization transfer contrast. , 2008, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[3]  K. Kashihara,et al.  Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson’s disease , 2011, Journal of Clinical Neuroscience.

[4]  Dorothee P Auer,et al.  In Vivo Assessment of Brainstem Depigmentation in Parkinson Disease: Potential as a Severity Marker for Multicenter Studies. , 2017, Radiology.

[5]  R Weissleder,et al.  Paramagnetic metal scavenging by melanin: MR imaging. , 1997, Radiology.

[6]  Abbas F. Sadikot,et al.  Patch-based label fusion segmentation of brainstem structures with dual-contrast MRI for Parkinson’s disease , 2015, International Journal of Computer Assisted Radiology and Surgery.

[7]  Nicolas Guizard,et al.  Investigation of morphometric variability of subthalamic nucleus, red nucleus, and substantia nigra in advanced Parkinson's disease patients using automatic segmentation and PCA‐based analysis , 2014, Human brain mapping.

[8]  Dorothee P Auer,et al.  T1‐Weighted MRI shows stage‐dependent substantia nigra signal loss in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[9]  Daniel Rueckert,et al.  Comparison and Evaluation of Segmentation Techniques for Subcortical Structures in Brain MRI , 2008, MICCAI.

[10]  Eri Shibata,et al.  Neuromelanin-Sensitive MRI : Basics, Technique, and Clinical Applications (Review Article) , 2008 .

[11]  Sergio Cerutti,et al.  Contrast mechanisms associated with neuromelanin‐MRI , 2017, Magnetic resonance in medicine.

[12]  Josien P W Pluim,et al.  Multiatlas-based segmentation with preregistration atlas selection. , 2013, Medical physics.

[13]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[14]  Mert R. Sabuncu,et al.  Multi-atlas segmentation of biomedical images: A survey , 2014, Medical Image Anal..

[15]  Cyril Poupon,et al.  7 tesla magnetic resonance imaging: A closer look at substantia nigra anatomy in Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[16]  Shinya Fujii,et al.  Correlation between pathology and neuromelanin MR imaging in Parkinson’s disease and dementia with Lewy bodies , 2013, Neuroradiology.

[17]  Delbert Dueck,et al.  Clustering by Passing Messages Between Data Points , 2007, Science.

[18]  C. Morgado,et al.  Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients , 2015, European journal of neurology.

[19]  Eri Shibata,et al.  Age-related changes in locus ceruleus on neuromelanin magnetic resonance imaging at 3 Tesla. , 2006, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[20]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.

[21]  Carlos Ortiz-de-Solorzano,et al.  Atlas-based segmentation of brainstem regions in neuromelanin-sensitive magnetic resonance images , 2015, Medical Imaging.

[22]  Notger G. Müller,et al.  Optimal Cut-Off Value for Locus Coeruleus-to-Pons Intensity Ratio as Clinical Biomarker for Alzheimer’s Disease: A Pilot Study , 2017, Journal of Alzheimer's disease reports.

[23]  Jesper Jeppesen,et al.  Evaluation of the noradrenergic system in Parkinson’s disease: an 11C-MeNER PET and neuromelanin MRI study , 2018, Brain : a journal of neurology.

[24]  Yasuo Terayama,et al.  Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease , 2006, Neuroreport.

[25]  Max A. Viergever,et al.  elastix: A Toolbox for Intensity-Based Medical Image Registration , 2010, IEEE Transactions on Medical Imaging.

[26]  Hiroki Shirato,et al.  3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson’s disease , 2013, Neuroradiology.

[27]  Carlos Ortiz-de-Solorzano,et al.  Combination Strategies in Multi-Atlas Image Segmentation: Application to Brain MR Data , 2009, IEEE Transactions on Medical Imaging.

[28]  C. Adler,et al.  Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. , 2013, Brain : a journal of neurology.

[29]  Meritxell Bach Cuadra,et al.  A review of atlas-based segmentation for magnetic resonance brain images , 2011, Comput. Methods Programs Biomed..

[30]  Benoit M. Dawant,et al.  Morphometric analysis of white matter lesions in MR images: method and validation , 1994, IEEE Trans. Medical Imaging.

[31]  Masayuki Satoh,et al.  A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson’s disease , 2016, Neuroscience Letters.

[32]  Silvia Marino,et al.  Differences between conventional and non-conventional MRI techniques in Parkinson’s disease , 2013 .

[33]  Yasuo Terayama,et al.  Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging , 2013, Neuroscience Letters.

[34]  Dimo Ivanov,et al.  High-resolution in vivo imaging of human locus coeruleus by magnetization transfer MRI at 3T and 7T , 2017, NeuroImage.

[35]  Angelo Antonini,et al.  Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease. , 2017, Journal of Parkinson's disease.

[36]  Mark A. Eckert,et al.  Histologic validation of locus coeruleus MRI contrast in post-mortem tissue , 2015, NeuroImage.

[37]  Carlos Ortiz-de-Solorzano,et al.  Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease , 2015, Movement disorders : official journal of the Movement Disorder Society.